420 related articles for article (PubMed ID: 29322803)
21. Medication-related osteonecrosis of the jaw after once-a-year intravenous zoledronic acid infusion for osteoporosis: Report of eight cases.
Favia G; Tempesta A; Limongelli L; Crincoli V; Maiorano E
Quintessence Int; 2016; 47(5):433-40. PubMed ID: 26665262
[TBL] [Abstract][Full Text] [Related]
22. Medication-Related Osteonecrosis of Jaws (MRONJ) Prevention and Diagnosis: Italian Consensus Update 2020.
Campisi G; Mauceri R; Bertoldo F; Bettini G; Biasotto M; Colella G; Consolo U; Di Fede O; Favia G; Fusco V; Gabriele M; Lo Casto A; Lo Muzio L; Marcianò A; Mascitti M; Meleti M; Mignogna MD; Oteri G; Panzarella V; Romeo U; Santarelli A; Vescovi P; Marchetti C; Bedogni A
Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32824826
[TBL] [Abstract][Full Text] [Related]
23. Osteoporosis therapy in patients with inflammatory rheumatic diseases and osteonecrosis of the jaw.
Schwaneck EC; Streit A; Krone M; Hartmann S; Müller-Richter U; Kübler AC; Gadeholt O; Schmalzing M; Tony HP; Brands RC
Z Rheumatol; 2020 Mar; 79(2):203-209. PubMed ID: 30796524
[TBL] [Abstract][Full Text] [Related]
24. Medication-related osteonecrosis of the jaw associated with bisphosphonates and denosumab in osteoporosis.
Bagan J; Peydró A; Calvo J; Leopoldo M; Jiménez Y; Bagan L
Oral Dis; 2016 May; 22(4):324-9. PubMed ID: 26818808
[TBL] [Abstract][Full Text] [Related]
25. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
[TBL] [Abstract][Full Text] [Related]
26. Sex difference in the morbidity and pain response with stage 0 of medication-related osteonecrosis of the jaws.
Zhang W; Gao R; Cui Y; Ding F; Zhu S; Luo S; Liu H; Li M
J Oral Biosci; 2023 Dec; 65(4):324-333. PubMed ID: 37543255
[TBL] [Abstract][Full Text] [Related]
27. Bisphosphonate-related osteonecrosis of the jaw in patients with breast cancer.
Piccioli A
Eur J Orthop Surg Traumatol; 2015 Jan; 25(1):29-37. PubMed ID: 24037511
[TBL] [Abstract][Full Text] [Related]
28. Medication-related osteonecrosis of the jaws from once per year intravenous zoledronic acid (Reclast): report of 4 cases.
Lee CY; Suzuki JB
Implant Dent; 2015 Apr; 24(2):227-31. PubMed ID: 25734948
[TBL] [Abstract][Full Text] [Related]
29. Infection and medication-related osteonecrosis of the jaw.
Katsarelis H; Shah NP; Dhariwal DK; Pazianas M
J Dent Res; 2015 Apr; 94(4):534-9. PubMed ID: 25710950
[TBL] [Abstract][Full Text] [Related]
30. MRONJ risk of adjuvant bisphosphonates in early stage breast cancer.
Patel V; Mansi J; Ghosh S; Kwok J; Burke M; Reilly D; Nizarali N; Sproat C; Chia K
Br Dent J; 2018 Jan; 224(2):74-79. PubMed ID: 29242516
[TBL] [Abstract][Full Text] [Related]
31. Declining Incidence of Medication-Related Osteonecrosis of the Jaw in Patients With Cancer.
Sim IeW; Sanders KM; Borromeo GL; Seymour JF; Ebeling PR
J Clin Endocrinol Metab; 2015 Oct; 100(10):3887-93. PubMed ID: 26241323
[TBL] [Abstract][Full Text] [Related]
32. Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with antiresorptives. A report of 7 cases from the Copenhagen Cohort.
Abel Mahedi Mohamed H; Nielsen CEN; Schiodt M
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 Feb; 125(2):157-163. PubMed ID: 29221983
[TBL] [Abstract][Full Text] [Related]
33. Conservative surgical treatment of medication related osteonecrosis of the jaw (MRONJ) lesions in patients affected by osteoporosis exposed to oral bisphosphonates: 24 months follow-up.
Nisi M; Karapetsa D; Gennai S; Ramaglia L; Graziani F; Gabriele M
J Craniomaxillofac Surg; 2018 Jul; 46(7):1153-1158. PubMed ID: 29802059
[TBL] [Abstract][Full Text] [Related]
34. Radiographic bone loss and the risk of medication-related osteonecrosis of the jaw (MRONJ) in multiple myeloma patients-A retrospective case control study.
Wazzan T; Kashtwari D; Almaden WF; Gong Y; Chen Y; Moreb J; Katz J
Spec Care Dentist; 2018 Nov; 38(6):356-361. PubMed ID: 30194738
[TBL] [Abstract][Full Text] [Related]
35. Osteonecrosis of the jaw in patients treated with denosumab: A multicenter case series.
Aljohani S; Gaudin R; Weiser J; Tröltzsch M; Ehrenfeld M; Kaeppler G; Smeets R; Otto S
J Craniomaxillofac Surg; 2018 Sep; 46(9):1515-1525. PubMed ID: 29983309
[TBL] [Abstract][Full Text] [Related]
36. Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis.
Gaudin E; Seidel L; Bacevic M; Rompen E; Lambert F
J Clin Periodontol; 2015 Oct; 42(10):922-32. PubMed ID: 26362756
[TBL] [Abstract][Full Text] [Related]
37. Radiological manifestations and clinical findings of patients with oncologic and osteoporotic medication-related osteonecrosis of the jaw.
Shin JW; Kim JE; Huh KH; Yi WJ; Heo MS; Lee SS; Choi SC
Sci Rep; 2024 Apr; 14(1):8744. PubMed ID: 38627515
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
[TBL] [Abstract][Full Text] [Related]
39. "Spontaneous" medication-related osteonecrosis of the jaw; two case reports and a systematic review.
Khominsky A; Lim M
Aust Dent J; 2018 Dec; 63(4):441-454. PubMed ID: 30144095
[TBL] [Abstract][Full Text] [Related]
40. Medical and Dental Professions' Varying Levels of Awareness Regarding Medication-related Osteonecrosis of the Jaw in Saudi Arabia? A Cross-sectional Study.
Aljohani MH; Aljohani AS; Aljohani RM; Alsharif WK; Nourwali I; Elsayed SA
J Contemp Dent Pract; 2024 Jan; 25(1):62-67. PubMed ID: 38514433
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]